Cargando…

Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV

Severe acute respiratory coronavirus (SARS-CoV) emerged in 2002, resulting in roughly 8000 cases worldwide and 10% mortality. The animal reservoirs for SARS-CoV precursors still exist and the likelihood of future outbreaks in the human population is high. The SARS-CoV papain-like protease (PLP) is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frieman, Matthew, Basu, Dipanwita, Matthews, Krystal, Taylor, Justin, Jones, Grant, Pickles, Raymond, Baric, Ralph, Engel, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229576/ https://www.ncbi.nlm.nih.gov/pubmed/22164298 http://dx.doi.org/10.1371/journal.pone.0028479

Ejemplares similares

A Yeast Suppressor Screen Used To Identify Mammalian SIRT1 as a Proviral Factor for Middle East Respiratory Syndrome Coronavirus Replication
por: Weston, Stuart, et al.
Publicado: (2019)

Resurrection of an “Extinct” SARS-CoV Isolate GD03 from LATE 2003
por: Sheahan, Timothy, et al.
Publicado: (2006)

Sars Cov Replication and Pathogenesis in Human Airway Airway Epithelial Cultures
por: Sims, Amy C., et al.
Publicado: (2006)

SARS coronavirus and innate immunity
por: Frieman, Matthew, et al.
Publicado: (2008)

Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen
por: Arnoldo, Anthony, et al.
Publicado: (2008)

The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity
por: Matthews, Krystal, et al.
Publicado: (2014)

Correction: Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen
por: Arnoldo, Anthony, et al.
Publicado: (2008)

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
por: Weston, Stuart, et al.
Publicado: (2020)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease
por: Canal, Berta, et al.
Publicado: (2021)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase
por: Basu, Souradeep, et al.
Publicado: (2021)

Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein
por: Sun, Chuancai, et al.
Publicado: (2021)

Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection
por: Cui, Qi, et al.
Publicado: (2021)

Development of Small-Molecule MERS-CoV Inhibitors
por: Liang, Ruiying, et al.
Publicado: (2018)

Use of a Fission Yeast Platform to Identify and Characterize Small Molecule PDE Inhibitors
por: Hoffman, Charles S.
Publicado: (2022)

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
por: Day, Craig W., et al.
Publicado: (2009)

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients
por: Dennison, Jessica L., et al.
Publicado: (2022)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease
por: Canal, Berta, et al.
Publicado: (2021)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
por: Zeng, Jingkun, et al.
Publicado: (2021)

SARS-CoV: Lessons for global health
por: Baric, Ralph Steven
Publicado: (2008)

Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
por: Rockx, Barry, et al.
Publicado: (2010)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
por: Milligan, Jennifer C., et al.
Publicado: (2021)

Yeast-based screen for inhibitors of Aβ oligomerisation
Publicado: (2011)

Small-molecule inhibitors of carboxylesterase Notum
por: Zhao, Yuguang, et al.
Publicado: (2021)

Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads
por: Taylor, Kerrie L, et al.
Publicado: (2010)

SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease
por: Lim, Chew Theng, et al.
Publicado: (2021)

Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes
por: Little, Peter J., et al.
Publicado: (2009)

SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
por: Frieman, Matthew B., et al.
Publicado: (2010)

Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner
por: Walkiewicz, Marcin P., et al.
Publicado: (2011)

Identification Of Small Molecule TRABID Deubiquitinase Inhibitors By Computation-Based Virtual Screen
por: Shi, Tong, et al.
Publicado: (2012)

Screening and identification of small molecule inhibitors of ErbB2‐induced invasion
por: Brix, D.M., et al.
Publicado: (2014)

Small molecule inhibitors of mesotrypsin from a structure-based docking screen
por: Kayode, Olumide, et al.
Publicado: (2017)

Cell‐based high‐throughput screen for small molecule inhibitors of Bax translocation
por: Hui, Kelvin Kai‐Wan, et al.
Publicado: (2018)

Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products
por: Du, Yue, et al.
Publicado: (2022)

Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
por: Deming, Damon, et al.
Publicado: (2006)

Identification of potent small molecule inhibitors of SARS-CoV-2 entry
por: Mediouni, Sonia, et al.
Publicado: (2022)

Correction: Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
por: Deming, Damon, et al.
Publicado: (2007)

p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
por: Andreotti, Virginia, et al.
Publicado: (2011)

Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6d7q7j3qidhssd7h17sdv1aipl